ADMA Biologics

YTD

ALL

Trade ADMA Biologics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ADMA

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate.

CEO

Adam S. Grossman

CEOAdam S. Grossman

Employees

685

Employees685

Headquarters

Ramsey, New Jersey

HeadquartersRamsey, New Jersey

Founded

2004

Founded2004

Employees

685

Employees685

ADMA Key Statistics

Market cap

3.43B

Market cap3.43B

Price-Earnings ratio

16.91

Price-Earnings ratio16.91

Dividend yield

—

Dividend yield—

Average volume

3.48M

Average volume3.48M

High today

$14.60

High today$14.60

Low today

$14.30

Low today$14.30

Open price

$14.43

Open price$14.43

Volume

2.11M

Volume2.11M

52 Week high

$25.67

52 Week high$25.67

52 Week low

$13.50

52 Week low$13.50

ADMA News

Simply Wall St 2d

Does ADMA Biologics’ Margin Expansion and Revenue Targets Signal a New Phase for ADMA?

ADMA Biologics has reaffirmed its multi-year growth outlook, projecting total revenues to exceed US$500 million in 2025 and reach at least US$625 million in 202...

People also own

Based on the portfolios of people who own ADMA. This list is generated using Robinhood data, and it’s not a recommendation.